In the ABYSS trial, researchers found that interrupting a beta-blocker in patients after a myocardial infarction resulted in ...

A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

The following is a summary of “Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI ...

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...

During a massive heart attack, a large portion of the heart doesn’t receive oxygen due to a blocked artery. Quick treatment ...

Since the 1960s, cardiologists have adopted several binary classification systems for acute myocardial infarction (MI) that ...

JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved ...

Hospitals whose emergency department (ED) triage of patients with suspected cardiac conditions was informed by an artificial ...

Powerful Medical, a leading innovator in AI-powered cardiology solutions, is proud to announce the appointment of Dr. Timothy ...

BACKGROUND: Cardiac troponin (cTn) is key in diagnosing myocardial infarction (MI). After MI, the clinically observed half-life of cTn has been reported to be 7 to 20 hours, but this estimate reflects ...